Circumcision and Risk of Febrile Urinary Tract Infection in Boys with Posterior Urethral Valves: Result of the CIRCUP Randomized Trial.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 26 03 2021
accepted: 25 08 2021
pubmed: 27 9 2021
medline: 19 4 2022
entrez: 26 9 2021
Statut: ppublish

Résumé

Boys with posterior urethral valves (PUVs) have an increased risk of febrile urinary tract infections (fUTIs). Circumcision is believed to reduce the risk of fUTIs in boys, although there are no randomized trials demonstrating this. To determine the effect of circumcision on the risk of fUTIs in boys with PUVs. A clinical randomized trial that ran between August 2012 and July 2017 was conducted. The trial was multicentric, including 13 referral centers for pediatric urology. Male boys, aged 1-28 d, diagnosed with posterior urethral valves, confirmed by voiding cystogram, were included. The exclusion criteria included presence of a genital malformation contraindicating performing a circumcision. Participants were randomized to neonatal circumcision + antibiotic prophylaxis (CATB) or antibiotic prophylaxis alone (ATB), and followed for 2 yr. The primary outcome was a risk of presenting fUTIs in each group. An fUTI was defined as fever (>38.5 °C) with evidence of pyuria and culture-proven infection on urinalysis, obtained by urethral catheterization or suprapubic aspiration. A bivariate analysis of the primary outcome was performed using the Kaplan-Meier method. In total, 91 patients were included: 49 in group CATB and 42 in group ATB. The probability of presenting an fUTI was 20% in group ATB versus 3% in group CATB. The hazard ratio of presenting an fUTI within 2 yr in the ATB group compared with that in the CATB group was 10.3 (95% confidence interval: 1.3-82.5). Sixty-four children (70.3%) had a complete follow-up at 2 yr of age. Circumcision significantly decreases the risk of presenting an fUTI in boys with PUVs. In this report, we compared, in a multicentric trial, the number of febrile urinary tract infections (UTIs) in boys with posterior urethral valves who had either antibiotic prophylaxis alone or antibiotic prophylaxis and circumcision. We found that those who had a circumcision had a significantly lower risk of febrile UTIs.

Sections du résumé

BACKGROUND BACKGROUND
Boys with posterior urethral valves (PUVs) have an increased risk of febrile urinary tract infections (fUTIs). Circumcision is believed to reduce the risk of fUTIs in boys, although there are no randomized trials demonstrating this.
OBJECTIVE OBJECTIVE
To determine the effect of circumcision on the risk of fUTIs in boys with PUVs.
DESIGN, SETTING, AND PARTICIPANTS METHODS
A clinical randomized trial that ran between August 2012 and July 2017 was conducted. The trial was multicentric, including 13 referral centers for pediatric urology. Male boys, aged 1-28 d, diagnosed with posterior urethral valves, confirmed by voiding cystogram, were included. The exclusion criteria included presence of a genital malformation contraindicating performing a circumcision.
INTERVENTION METHODS
Participants were randomized to neonatal circumcision + antibiotic prophylaxis (CATB) or antibiotic prophylaxis alone (ATB), and followed for 2 yr.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS METHODS
The primary outcome was a risk of presenting fUTIs in each group. An fUTI was defined as fever (>38.5 °C) with evidence of pyuria and culture-proven infection on urinalysis, obtained by urethral catheterization or suprapubic aspiration. A bivariate analysis of the primary outcome was performed using the Kaplan-Meier method.
RESULTS AND LIMITATIONS CONCLUSIONS
In total, 91 patients were included: 49 in group CATB and 42 in group ATB. The probability of presenting an fUTI was 20% in group ATB versus 3% in group CATB. The hazard ratio of presenting an fUTI within 2 yr in the ATB group compared with that in the CATB group was 10.3 (95% confidence interval: 1.3-82.5). Sixty-four children (70.3%) had a complete follow-up at 2 yr of age.
CONCLUSIONS CONCLUSIONS
Circumcision significantly decreases the risk of presenting an fUTI in boys with PUVs.
PATIENT SUMMARY RESULTS
In this report, we compared, in a multicentric trial, the number of febrile urinary tract infections (UTIs) in boys with posterior urethral valves who had either antibiotic prophylaxis alone or antibiotic prophylaxis and circumcision. We found that those who had a circumcision had a significantly lower risk of febrile UTIs.

Identifiants

pubmed: 34563412
pii: S0302-2838(21)01993-X
doi: 10.1016/j.eururo.2021.08.024
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-72

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Luke Harper (L)

Department of Pediatric Surgery, CHU de La Réunion, Saint Denis de La Réunion, France; Department of Pediatric Surgery and Urology, University Hospital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, France. Electronic address: Harper_luke@hotmail.com.

T Blanc (T)

Department of Pediatric Surgery and Urology, APHP, Hôpital Necker, Paris, France.

M Peycelon (M)

Department of Pediatric Urology, University Hospital Robert Debre, APHP, University of Paris, Centre de Référence des Malformations Rares des Voies Urinaires (MARVU), Paris, France.

J L Michel (JL)

Department of Pediatric Surgery, CHU de La Réunion, Saint Denis de La Réunion, France.

M D Leclair (MD)

Department of Pediatric Surgery and Urology, Children's University Hospital, CHU de Nantes, Nantes, France.

S Garnier (S)

Department of Pediatric Surgery and Urology, Lapeyronie University Hospital, CHU de Montpellier, Montpellier, France.

V Flaum (V)

Department of Pediatric Surgery, Armand Trousseau Children's University Hospital, Paris, France.

A P Arnaud (AP)

Department of Pediatric Surgery, Rennes University Hospital, CHU de Rennes, Rennes, France.

T Merrot (T)

Department of Pediatric Surgery, North and Timone Children's Hospital, Assistance Publique Hopitaux de Marseille, Aix-Marseille Université, Marseille, France.

E Dobremez (E)

Department of Pediatric Surgery and Urology, University Hospital Pellegrin-Enfants, CHU de Bordeaux, Bordeaux, France.

A Faure (A)

Department of Pediatric Surgery, North and Timone Children's Hospital, Assistance Publique Hopitaux de Marseille, Aix-Marseille Université, Marseille, France.

L Fourcade (L)

Department of Pediatric Surgery, University Hospital, CHU de Limoges, Limoges, France.

M L Poli-Merol (ML)

Department of Pediatric Surgery, Reims University Hospital, Reims, France.

Y Chaussy (Y)

Department of Pediatric Surgery, Besançon University Hospital, CHU de Besançon, Besançon, France.

O Dunand (O)

Department of Pediatric Nephrology, CHU de La Réunion, Saint-Denis de La Réunion, France.

F Collin (F)

Clinical Research Department, INSERM, CIC1410, CHU de la Réunion, Saint-Pierre, France.

L Huiart (L)

Clinical Research Department, INSERM, CIC1410, CHU de la Réunion, Saint-Pierre, France.

C Ferdynus (C)

Clinical Research Department, INSERM, CIC1410, CHU de la Réunion, Saint-Pierre, France; Unité de Soutien Méthodologique, CHU de La Réunion, Saint-Denis de La Réunion, France.

F Sauvat (F)

Department of Pediatric Surgery, CHU de La Réunion, Saint Denis de La Réunion, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH